APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Analysis and Forecast 2026-2032

2 January 2026205 pages

Choose your research edition.

Industry ResearchVaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) include CNADC, Guangdong Yongshun Biological Pharmaceutical Co Ltd, Tiankang, Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health, Plec Bioengineering Co., Ltd., Jinyu Bio-Technology, Sinopharm and Guangdong Wens Dahuanong Biotechnology Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), also provides the sales of main regions and countries. Of the upcoming market potential for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales, projected growth trends, production technology, application and end-user industry.

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Company

CNADC

Guangdong Yongshun Biological Pharmaceutical Co Ltd

Tiankang

Tianjin Ruipu Biological Technology Co., Ltd.

Qilu Animal Health

Plec Bioengineering Co., Ltd.

Jinyu Bio-Technology

Sinopharm

Guangdong Wens Dahuanong Biotechnology Co., Ltd.

Chengdu Tianbang Biological Products Co., Ltd.

Boehringer-Ingelheim

Zoetis

Phibro Animal Health

MSD Animal Health

Komipharm

Ceva

CAVAC

Bioveta

Agrovet

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type

Live Vaccine

Inactivated Vaccine

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application

Government Tender

Marketing

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Vaccine Major Manufacturers Table 3. Inactivated Vaccine Major Manufacturers Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Government Tender Major Manufacturers Table 6. Marketing Major Manufacturers Table 7. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends Table 8. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Drivers Table 9. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Opportunities and Challenges Table 10. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Restraints Table 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2021-2026) Table 15. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2027-2032) Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2021-2026) & (K Units) Table 18. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2027-2032) & (K Units) Table 19. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2021-2026) Table 20. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2027-2032) Table 21. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2021-2026) Table 25. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers, Product Type & Application Table 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2021-2026) Table 36. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2027-2032) Table 37. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 39. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (K Units) Table 40. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2021-2026) Table 41. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2027-2032) Table 42. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2026) & (US$/Unit) Table 43. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2027-2032) & (US$/Unit) Table 44. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2021-2026) Table 48. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2027-2032) Table 49. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 51. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (K Units) Table 52. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2021-2026) Table 53. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2027-2032) Table 54. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2026) & (US$/Unit) Table 55. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2027-2032) & (US$/Unit) Table 56. CNADC Company Information Table 57. CNADC Business Overview Table 58. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 60. CNADC Recent Development Table 61. Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information Table 62. Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview Table 63. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 65. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Development Table 66. Tiankang Company Information Table 67. Tiankang Business Overview Table 68. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 70. Tiankang Recent Development Table 71. Tianjin Ruipu Biological Technology Co., Ltd. Company Information Table 72. Tianjin Ruipu Biological Technology Co., Ltd. Business Overview Table 73. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 75. Tianjin Ruipu Biological Technology Co., Ltd. Recent Development Table 76. Qilu Animal Health Company Information Table 77. Qilu Animal Health Business Overview Table 78. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 80. Qilu Animal Health Recent Development Table 81. Plec Bioengineering Co., Ltd. Company Information Table 82. Plec Bioengineering Co., Ltd. Business Overview Table 83. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 85. Plec Bioengineering Co., Ltd. Recent Development Table 86. Jinyu Bio-Technology Company Information Table 87. Jinyu Bio-Technology Business Overview Table 88. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 90. Jinyu Bio-Technology Recent Development Table 91. Sinopharm Company Information Table 92. Sinopharm Business Overview Table 93. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 95. Sinopharm Recent Development Table 96. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information Table 97. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview Table 98. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 100. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Development Table 101. Chengdu Tianbang Biological Products Co., Ltd. Company Information Table 102. Chengdu Tianbang Biological Products Co., Ltd. Business Overview Table 103. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 105. Chengdu Tianbang Biological Products Co., Ltd. Recent Development Table 106. Boehringer-Ingelheim Company Information Table 107. Boehringer-Ingelheim Business Overview Table 108. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 110. Boehringer-Ingelheim Recent Development Table 111. Zoetis Company Information Table 112. Zoetis Business Overview Table 113. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 115. Zoetis Recent Development Table 116. Phibro Animal Health Company Information Table 117. Phibro Animal Health Business Overview Table 118. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 120. Phibro Animal Health Recent Development Table 121. MSD Animal Health Company Information Table 122. MSD Animal Health Business Overview Table 123. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 125. MSD Animal Health Recent Development Table 126. Komipharm Company Information Table 127. Komipharm Business Overview Table 128. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 130. Komipharm Recent Development Table 131. Ceva Company Information Table 132. Ceva Business Overview Table 133. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 135. Ceva Recent Development Table 136. CAVAC Company Information Table 137. CAVAC Business Overview Table 138. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 140. CAVAC Recent Development Table 141. Bioveta Company Information Table 142. Bioveta Business Overview Table 143. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 145. Bioveta Recent Development Table 146. Agrovet Company Information Table 147. Agrovet Business Overview Table 148. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio Table 150. Agrovet Recent Development Table 151. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2026) & (US$ Million) Table 152. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2027-2032) & (US$ Million) Table 153. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 154. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (K Units) Table 155. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2021-2026) & (US$/Unit) Table 156. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2027-2032) & (US$/Unit) Table 157. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2026) & (US$ Million) Table 158. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2027-2032) & (US$ Million) Table 159. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 160. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (K Units) Table 161. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2021-2026) & (US$/Unit) Table 162. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2027-2032) & (US$/Unit) Table 163. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 167. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 168. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 169. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Country (2021-2026) & (US$/Unit) Table 170. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Country (2027-2032) & (US$/Unit) Table 171. United States Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 172. Canada Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 173. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2026) & (US$ Million) Table 174. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2027-2032) & (US$ Million) Table 175. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 176. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (K Units) Table 177. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2021-2026) & (US$/Unit) Table 178. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2027-2032) & (US$/Unit) Table 179. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2026) & (US$ Million) Table 180. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2027-2032) & (US$ Million) Table 181. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 182. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (K Units) Table 183. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2021-2026) & (US$/Unit) Table 184. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2027-2032) & (US$/Unit) Table 185. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 189. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 190. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 191. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Country (2021-2026) & (US$/Unit) Table 192. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Germany Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 194. France Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 195. U.K. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 196. Italy Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 197. Netherlands Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 198. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2026) & (US$ Million) Table 199. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2027-2032) & (US$ Million) Table 200. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 201. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (K Units) Table 202. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2021-2026) & (US$/Unit) Table 203. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2027-2032) & (US$/Unit) Table 204. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2026) & (US$ Million) Table 205. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2027-2032) & (US$ Million) Table 206. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 207. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (K Units) Table 208. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2021-2026) & (US$/Unit) Table 209. China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2027-2032) & (US$/Unit) Table 210. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2026) & (US$ Million) Table 211. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2027-2032) & (US$ Million) Table 212. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 213. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (K Units) Table 214. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2021-2026) & (US$/Unit) Table 215. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2027-2032) & (US$/Unit) Table 216. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2026) & (US$ Million) Table 217. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2027-2032) & (US$ Million) Table 218. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 219. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (K Units) Table 220. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2021-2026) & (US$/Unit) Table 221. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2027-2032) & (US$/Unit) Table 222. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 223. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 224. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 225. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 226. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 227. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 228. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Country (2021-2026) & (US$/Unit) Table 229. Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Country (2027-2032) & (US$/Unit) Table 230. Japan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 231. South Korea Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 232. India Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 233. Australia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 234. China Taiwan Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 235. Southeast Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 236. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2026) & (US$ Million) Table 237. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2027-2032) & (US$ Million) Table 238. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2026) & (K Units) Table 239. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2027-2032) & (K Units) Table 240. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2021-2026) & (US$/Unit) Table 241. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Type (2027-2032) & (US$/Unit) Table 242. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2026) & (US$ Million) Table 243. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2027-2032) & (US$ Million) Table 244. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2026) & (K Units) Table 245. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2027-2032) & (K Units) Table 246. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2021-2026) & (US$/Unit) Table 247. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Application (2027-2032) & (US$/Unit) Table 248. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 250. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 251. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 252. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021-2026) & (K Units) Table 253. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2027-2032) & (K Units) Table 254. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Country (2021-2026) & (US$/Unit) Table 255. SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Country (2027-2032) & (US$/Unit) Table 256. Brazil Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 257. Argentina Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 258. Chile Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 259. Colombia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 260. Peru Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 261. Saudi Arabia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 262. Israel Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 263. UAE Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 264. Turkey Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 265. Iran Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 266. Egypt Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2021-2032) & (US$ Million) Table 267. Key Raw Materials Table 268. Raw Materials Key Suppliers Table 269. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List Table 270. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers List Table 271. Research Programs/Design for This Report Table 272. Authors List of This Report Table 273. Secondary Sources Table 274. Primary Sources List of Figures Figure 1. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Image Figure 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Vaccine Image Figure 5. Inactivated Vaccine Image Figure 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Government Tender Image Figure 9. Marketing Image Figure 10. Global Vaccine for Porcine Reproductive

Scope & coverage.

Types
  • Live Vaccine
  • Inactivated Vaccine
Applications
  • Government Tender
  • Marketing
Companies covered
  • CNADC
  • Guangdong Yongshun Biological Pharmaceutical Co Ltd
  • Tiankang
  • Tianjin Ruipu Biological Technology Co., Ltd.
  • Qilu Animal Health
  • Plec Bioengineering Co., Ltd.
  • Jinyu Bio-Technology
  • Sinopharm
  • Guangdong Wens Dahuanong Biotechnology Co., Ltd.
  • Chengdu Tianbang Biological Products Co., Ltd.
  • Boehringer-Ingelheim
  • Zoetis
  • Phibro Animal Health
  • MSD Animal Health
  • Komipharm
  • Ceva
  • CAVAC
  • Bioveta
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Type
  3. 1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live Vaccine
  5. 1.2.3 Inactivated Vaccine
  6. 1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Application
  7. 1.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Government Tender
  9. 1.3.3 Marketing
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Dynamics
  1. 2.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
  2. 2.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Drivers
  3. 2.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Opportunities and Challenges
  4. 2.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region
  3. 3.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2021-2026)
  5. 3.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2027-2032)
  6. 3.2.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
  9. 3.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2021-2026)
  11. 3.4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2027-2032)
  12. 3.4.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Manufacturers
  2. 4.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Manufacturers
  6. 4.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers, Product Type & Application
  13. 4.7 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market CR5 and HHI
  16. 4.8.2 2025 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Tier 1, Tier 2, and Tier 3
5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Type
  1. 5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type
  2. 5.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type
  6. 5.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type
6 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Application
  1. 6.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application
  2. 6.1.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application
  6. 6.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application
7 Company Profiles
  1. 7.1 CNADC
  2. 7.1.1 CNADC Company Information
  3. 7.1.2 CNADC Business Overview
  4. 7.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  6. 7.1.5 CNADC Recent Developments
  7. 7.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd
  8. 7.2.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
  9. 7.2.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Business Overview
  10. 7.2.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  12. 7.2.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments
  13. 7.3 Tiankang
  14. 7.3.1 Tiankang Company Information
  15. 7.3.2 Tiankang Business Overview
  16. 7.3.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  18. 7.3.5 Tiankang Recent Developments
  19. 7.4 Tianjin Ruipu Biological Technology Co., Ltd.
  20. 7.4.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Information
  21. 7.4.2 Tianjin Ruipu Biological Technology Co., Ltd. Business Overview
  22. 7.4.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  24. 7.4.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments
  25. 7.5 Qilu Animal Health
  26. 7.5.1 Qilu Animal Health Company Information
  27. 7.5.2 Qilu Animal Health Business Overview
  28. 7.5.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  30. 7.5.5 Qilu Animal Health Recent Developments
  31. 7.6 Plec Bioengineering Co., Ltd.
  32. 7.6.1 Plec Bioengineering Co., Ltd. Company Information
  33. 7.6.2 Plec Bioengineering Co., Ltd. Business Overview
  34. 7.6.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  36. 7.6.5 Plec Bioengineering Co., Ltd. Recent Developments
  37. 7.7 Jinyu Bio-Technology
  38. 7.7.1 Jinyu Bio-Technology Company Information
  39. 7.7.2 Jinyu Bio-Technology Business Overview
  40. 7.7.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  42. 7.7.5 Jinyu Bio-Technology Recent Developments
  43. 7.8 Sinopharm
  44. 7.8.1 Sinopharm Company Information
  45. 7.8.2 Sinopharm Business Overview
  46. 7.8.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  48. 7.8.5 Sinopharm Recent Developments
  49. 7.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
  50. 7.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
  51. 7.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Business Overview
  52. 7.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  54. 7.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments
  55. 7.10 Chengdu Tianbang Biological Products Co., Ltd.
  56. 7.10.1 Chengdu Tianbang Biological Products Co., Ltd. Company Information
  57. 7.10.2 Chengdu Tianbang Biological Products Co., Ltd. Business Overview
  58. 7.10.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  60. 7.10.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments
  61. 7.11 Boehringer-Ingelheim
  62. 7.11.1 Boehringer-Ingelheim Company Information
  63. 7.11.2 Boehringer-Ingelheim Business Overview
  64. 7.11.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  66. 7.11.5 Boehringer-Ingelheim Recent Developments
  67. 7.12 Zoetis
  68. 7.12.1 Zoetis Company Information
  69. 7.12.2 Zoetis Business Overview
  70. 7.12.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  72. 7.12.5 Zoetis Recent Developments
  73. 7.13 Phibro Animal Health
  74. 7.13.1 Phibro Animal Health Company Information
  75. 7.13.2 Phibro Animal Health Business Overview
  76. 7.13.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  78. 7.13.5 Phibro Animal Health Recent Developments
  79. 7.14 MSD Animal Health
  80. 7.14.1 MSD Animal Health Company Information
  81. 7.14.2 MSD Animal Health Business Overview
  82. 7.14.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  84. 7.14.5 MSD Animal Health Recent Developments
  85. 7.15 Komipharm
  86. 7.15.1 Komipharm Company Information
  87. 7.15.2 Komipharm Business Overview
  88. 7.15.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  90. 7.15.5 Komipharm Recent Developments
  91. 7.16 Ceva
  92. 7.16.1 Ceva Company Information
  93. 7.16.2 Ceva Business Overview
  94. 7.16.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  96. 7.16.5 Ceva Recent Developments
  97. 7.17 CAVAC
  98. 7.17.1 CAVAC Company Information
  99. 7.17.2 CAVAC Business Overview
  100. 7.17.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  102. 7.17.5 CAVAC Recent Developments
  103. 7.18 Bioveta
  104. 7.18.1 Bioveta Company Information
  105. 7.18.2 Bioveta Business Overview
  106. 7.18.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  108. 7.18.5 Bioveta Recent Developments
  109. 7.19 Agrovet
  110. 7.19.1 Agrovet Company Information
  111. 7.19.2 Agrovet Business Overview
  112. 7.19.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Portfolio
  114. 7.19.5 Agrovet Recent Developments
8 North America
  1. 8.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
  2. 8.1.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2032)
  3. 8.1.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032)
  4. 8.1.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2032)
  5. 8.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
  6. 8.2.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2032)
  7. 8.2.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032)
  8. 8.2.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2032)
  9. 8.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  10. 8.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
  2. 9.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032)
  4. 9.1.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2032)
  5. 9.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
  6. 9.2.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032)
  8. 9.2.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2032)
  9. 9.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  10. 9.3.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
  2. 10.1.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2032)
  3. 10.1.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032)
  4. 10.1.3 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2032)
  5. 10.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
  6. 10.2.1 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2032)
  7. 10.2.2 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032)
  8. 10.2.3 China Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
  2. 11.1.1 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032)
  4. 11.1.3 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2032)
  5. 11.2 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
  6. 11.2.1 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032)
  8. 11.2.3 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2032)
  9. 11.3 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  10. 11.3.1 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
  2. 12.1.1 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2021-2032)
  5. 12.2 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
  6. 12.2.1 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2021-2032)
  9. 12.3 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Country
  10. 12.3.1 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Value Chain Analysis
  2. 13.1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Production Mode & Process
  6. 13.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors
  9. 13.2.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst